The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 27, 2024

Filed:

Apr. 22, 2021
Applicant:

Opko Renal, Llc, Miami, FL (US);

Inventors:

Charles W. Bishop, Miami, FL (US);

Keith H. Crawford, Parker, CO (US);

Eric J. Messner, Lake Forest, IL (US);

Assignee:

OPKO RENAL, LLC, Miami, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/593 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 31/592 (2006.01); A61K 9/16 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 31/593 (2013.01); A61K 9/00 (2013.01); A61K 9/0019 (2013.01); A61K 9/16 (2013.01); A61K 9/48 (2013.01); A61K 9/4808 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 9/4875 (2013.01); A61K 31/592 (2013.01); A61K 47/26 (2013.01);
Abstract

Methods and compositions for treating 25-hydroxyvitamin D insufficiency and deficiency in a patient are described herein. The method includes orally administering to the patient a delayed, sustained release formulation including a first ingredient selected from the group consisting of 25-hydroxyvitamin D, 25-hydroxyvitamin D, or a combination of 25-hydroxyvitamin Dand 25-hydroxyvitamin D, or it includes gradually administering to the patient a sterile intravenous formulation including a first ingredient selected from the group consisting of 25-hydroxyvitamin D, 25-hydroxyvitamin D, or a combination of 25-hydroxyvitamin Dand 25-hydroxyvitamin D.


Find Patent Forward Citations

Loading…